KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances: 2011-2018

Historic Long-Term Debt Issuances for Sarepta Therapeutics (SRPT) over the last 2 years, with Dec 2018 value amounting to $18.1 million.

  • Sarepta Therapeutics' Long-Term Debt Issuances fell 96.64% to $18.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $235.9 million, marking a year-over-year decrease of 56.38%. This contributed to the annual value of $1.1 billion for FY2022, which is N/A change from last year.
  • According to the latest figures from Q4 2018, Sarepta Therapeutics' Long-Term Debt Issuances is $18.1 million, which was down 59.09% from $44.4 million recorded in Q3 2018.
  • Sarepta Therapeutics' 5-year Long-Term Debt Issuances high stood at $540.4 million for Q4 2017, and its period low was -$133,000 during Q3 2015.
  • For the 2-year period, Sarepta Therapeutics' Long-Term Debt Issuances averaged around $155.3 million, with its median value being $77.1 million (2018).
  • Data for Sarepta Therapeutics' Long-Term Debt Issuances shows a maximum YoY tumbled of 96.64% (in 2018) over the last 5 years.
  • Over the past 3 years, Sarepta Therapeutics' Long-Term Debt Issuances (Quarterly) stood at $399,000 in 2015, then reached $540.4 million in 2017, then crashed by 96.64% to $18.1 million in 2018.
  • Its Long-Term Debt Issuances stands at $18.1 million for Q4 2018, versus $44.4 million for Q3 2018 and $77.1 million for Q2 2018.